ASR Vermogensbeheer N.V. Boosts Holdings in Molina Healthcare, Inc $MOH

ASR Vermogensbeheer N.V. boosted its position in shares of Molina Healthcare, Inc (NYSE:MOH) by 57.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,087 shares of the company’s stock after buying an additional 764 shares during the quarter. ASR Vermogensbeheer N.V.’s holdings in Molina Healthcare were worth $622,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD boosted its stake in Molina Healthcare by 46.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock worth $1,264,214,000 after buying an additional 1,216,903 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in shares of Molina Healthcare by 8.6% during the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company’s stock worth $490,099,000 after purchasing an additional 117,796 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Molina Healthcare by 42.7% during the first quarter. AQR Capital Management LLC now owns 884,958 shares of the company’s stock worth $288,125,000 after purchasing an additional 264,664 shares during the last quarter. Durable Capital Partners LP lifted its position in shares of Molina Healthcare by 13.1% during the first quarter. Durable Capital Partners LP now owns 541,605 shares of the company’s stock worth $178,399,000 after purchasing an additional 62,899 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Molina Healthcare by 1.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 465,672 shares of the company’s stock worth $153,388,000 after purchasing an additional 7,021 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms have recently weighed in on MOH. Sanford C. Bernstein decreased their target price on Molina Healthcare from $284.00 to $220.00 and set an “outperform” rating for the company in a research report on Friday, September 5th. Wells Fargo & Company decreased their target price on Molina Healthcare from $216.00 to $198.00 and set an “overweight” rating for the company in a research report on Friday, August 15th. UBS Group decreased their target price on Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Morgan Stanley downgraded Molina Healthcare from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $364.00 to $266.00 in a research report on Thursday, July 10th. Finally, Mizuho decreased their target price on Molina Healthcare from $400.00 to $330.00 and set an “outperform” rating for the company in a research report on Friday, July 11th. Three research analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Molina Healthcare has an average rating of “Hold” and an average price target of $225.18.

Molina Healthcare Stock Performance

MOH stock opened at $202.59 on Friday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. The business has a 50-day moving average price of $174.21 and a 200 day moving average price of $252.78. The company has a market capitalization of $10.98 billion, a P/E ratio of 9.98 and a beta of 0.55. Molina Healthcare, Inc has a 1-year low of $151.95 and a 1-year high of $359.97.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing the consensus estimate of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business’s revenue was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.86 earnings per share. As a group, equities research analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Ronna Romney sold 700 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the transaction, the director directly owned 17,131 shares in the company, valued at approximately $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO James Woys bought 10,000 shares of Molina Healthcare stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the completion of the acquisition, the chief operating officer directly owned 74,331 shares of the company’s stock, valued at $11,591,176.14. This represents a 15.54% increase in their position. The disclosure for this purchase can be found here. Insiders own 1.10% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.